abstract |
Methods of using an ET B receptor agonist, such as IRL-1620, for the treatment of stroke or cerebrovascular accidents are disclosed. The ET B receptor agonist is used alone or in combination with a second agent useful in the treatment of stroke or other cerebrovascular accident. |